Volume | 367 |
|
|||||
News | - | ||||||
Day High | 1.29 | Low High |
|||||
Day Low | 1.21 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
RenovoRx Inc | RNXT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.29 | 1.21 | 1.29 | 1.21 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
10 | 367 | US$ 1.21 | US$ 444 | - | 0.5306 - 3.29 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
09:54:17 | 2 | US$ 1.22 | USD |
RenovoRx Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
12.94M | 10.69M | - | 0 | -10.23M | -0.96 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
RenovoRx News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNXT Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.19 | 1.38 | 1.17 | 1.23 | 9,616 | 0.0201 | 1.69% |
1 Month | 1.34 | 1.56 | 1.10 | 1.18 | 63,234 | -0.1299 | -9.69% |
3 Months | 1.74 | 1.86 | 1.10 | 1.34 | 39,647 | -0.5299 | -30.45% |
6 Months | 1.04 | 2.35 | 0.5306 | 1.41 | 67,763 | 0.1701 | 16.36% |
1 Year | 3.05 | 3.29 | 0.5306 | 2.21 | 189,473 | -1.84 | -60.32% |
3 Years | 8.25 | 16.74 | 0.5306 | 7.73 | 465,930 | -7.04 | -85.33% |
5 Years | 8.25 | 16.74 | 0.5306 | 7.73 | 465,930 | -7.04 | -85.33% |
RenovoRx Description
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem. |